107 - Distilling Decades of MedTech Data, Generative AI, and Doing Without Tribal Knowledge with Michelle Wu

Let's Combinate · 25 Oct 2023 · 32m

What this episode covers

Michelle Wu, CEO and Founder of NyquistData, explains how her company uses generative AI to distill decades of MedTech data, removing the 'tribal knowledge' barrier for quality and regulatory professionals. She details the distinction between pre-trained models and fine-tuned algorithms, emphasizing that Nyquist’s data is validated and specific to FDA and global medical device regulations, unlike generic models like OpenAI. Wu discusses the challenge of changing organizational culture and overcoming skepticism in life sciences, highlighting features like the 'Device Explorer' and 'Data Writer' that democratize access to complex regulatory insights.

Mentioned

Companies
NyquistData, Anora.ai, Waveall Inc., Boston Consulting Group, Open AI, Deep Mind
Products
Nyquist, AI, ChatGPT, Device Explorer, Data Writer
Tools
Google BART, Vertex AI
Also
Google Accelerator, FDA

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 42m

    #439: MedTech AI Trends 2025: Scaling Regulatory Intelligence with Michelle Wu

    Michelle Wu, Founder and CEO of Nyquist AI, discusses the transformative impact of AI on the MedTech regulatory and quality assurance (RAQA) industry. She outlines the shift from AI skepticism to necessity, driven by the FDA’s ELSA framework and the EU AI Act, and introduces her 'Holy Trinity' framework of Data, Workflow, and Agents. Wu highlights how AI literacy can command a 56.8% salary premium for professionals and shares case studies of companies automating thousands of tasks, emphasizing that future success depends on asking high-quality strategic questions rather than memorizing knowledge.

  • Global Medical Device Podcast · 24m

    #345: Using AI In MedTech

    Wade Schroeder, Medical Device Guru at Greenlight Guru, discusses the state of AI in MedTech, highlighting that 65% of professionals distrust AI data accuracy due to unknown sources. He explains how Greenlight Guru’s Risk Intelligence tool uses Bayesian statistics and natural language processing to pull data from the FDA’s MAUDE database, helping engineers address the 'cold start' problem in risk management. Schroeder also introduces the 'Digital Guru,' an AI bot trained specifically on FDA regulations to ensure compliance and trust, contrasting it with general models like ChatGPT.

  • Global Medical Device Podcast · 44m

    #443: Generative AI in MedTech: Quality, Risks, and the Autonomy Scale with Ashkon Rasooli

    Ashkon Rasooli, founder of Ingenious Solutions and a specialist in Software as a Medical Device (SaMD), discusses the unique quality assurance challenges of generative AI in the medical device industry. He explains that unlike traditional machine learning, generative AI creates new data, introducing failure modes like 'hallucinations' where outputs appear plausible but are factually incorrect. Rasooli argues that because GenAI behavior is statistical rather than deterministic, traditional pre-market validation is insufficient, necessitating a shift toward continuous post-market surveillance and real-time independent monitoring to ensure safety.

  • Global Medical Device Podcast · 15m

    #460: FDA AI Regulations: Master the QA/RA Skills to Stay Ahead

    Etsy Nichols discusses the evolving FDA regulatory landscape for AI-enabled medical devices, highlighting the establishment of the Digital Health Center of Excellence and the shift toward rigorous documentation over algorithmic sophistication. She outlines five guiding principles for AI/ML-based Software as a Medical Device (SaMD) and emphasizes the critical importance of Predetermined Change Control Plans (PCCPs) in bridging US and EU regulatory requirements. Nichols argues that QA/RA professionals must combine regulatory fluency with AI literacy to navigate these complex systems effectively.

  • Global Medical Device Podcast · 45m

    #353: How Artificial Intelligence is Impacting the MedTech Industry

    Ashkon Rasooli, a biomedical engineer and quality management expert at Engenius Solutions, discusses the integration of AI in the MedTech industry, highlighting its statistical nature versus deterministic software. He details current applications in radiology, cardiology, and neurology, as well as wellness wearables like January AI and Whoop, while emphasizing the critical need to mitigate data bias in AI models. Rasooli also outlines a staged adoption strategy for validating AI tools within Quality Management Systems to manage inherent uncertainty, and touches on regulatory efforts by the AFDO/RAPS Working Group.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.